Abterra Biosciences, Inc.
Publicly observedSan Diego, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | San Diego | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Abterra Biosciences, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | TYHDLNB65NJ1 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant17 Aug 2026Publicly observed
NIH SBIR/STTR award: A platform for serum antibody repertoire analysis for autoimmune disease diagnosis
USD 306,555.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jun 2025Publicly observed
NIH SBIR/STTR award: REPTOR: accelerating antibody discovery and improving hits with machine learning
USD 63,564.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 Apr 2020Publicly observed
NIH SBIR/STTR award: REPTOR: accelerating antibody discovery and improving hits with machine learning
USD 961,244.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.